PLoS ONE (Jan 2011)

MicroRNA-restricted transgene expression in the retina.

  • Marianthi Karali,
  • Anna Manfredi,
  • Agostina Puppo,
  • Elena Marrocco,
  • Annagiusi Gargiulo,
  • Mariacarmela Allocca,
  • Michele Della Corte,
  • Settimio Rossi,
  • Massimo Giunti,
  • Maria Laura Bacci,
  • Francesca Simonelli,
  • Enrico Maria Surace,
  • Sandro Banfi,
  • Alberto Auricchio

DOI
https://doi.org/10.1371/journal.pone.0022166
Journal volume & issue
Vol. 6, no. 7
p. e22166

Abstract

Read online

Gene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies. Recently, microRNAs have been exploited to fine-tune transgene expression improving therapeutic outcomes. Here we evaluated the ability of retinal-expressed microRNAs to restrict AAV-mediated transgene expression to specific retinal cell types that represent the main targets of common inherited blinding conditions.To this end, we generated AAV2/5 vectors expressing EGFP and containing four tandem copies of miR-124 or miR-204 complementary sequences in the 3'UTR of the transgene expression cassette. These vectors were administered subretinally to adult C57BL/6 mice and Large White pigs. Our results demonstrate that miR-124 and miR-204 target sequences can efficiently restrict AAV2/5-mediated transgene expression to retinal pigment epithelium and photoreceptors, respectively, in mice and pigs. Interestingly, transgene restriction was observed at low vector doses relevant to therapy.We conclude that microRNA-mediated regulation of transgene expression can be applied in the retina to either restrict to a specific cell type the robust expression obtained using ubiquitous promoters or to provide an additional layer of gene expression regulation when using cell-specific promoters.